BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Feb. 11, 2004
View Archived Issues
Ark Seeks Listing On London Stock Exchange Via £50 IPO
LONDON - Ark Therapeutics Group plc is feeling out investor appetite for what would be the first listing of a biotechnology company on the main market of the London Stock Exchange in three years. (BioWorld International)
Read More
CAT Reports CAT-192 Results With Genzyme, Ends Elan Deal
Read More
Structure Of 1918 Flu Virus Holds Clue To Its Virulence
Read More
Hurdles For Europe Include Tissue Engineering, Patents
Read More
Advancements In SiRNA Spur Strategy Change For Atugen
Read More
BiondVax Raises $4M For Multiseason Nasal Vaccine
Read More
Other News To Note
Read More